Back to Trials
NCT06400550Recruiting

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

University of Texas Southwestern Medical Center

Start Date

8/1/2018

Completion Date

8/1/2028

Summary

The goal of this study is to observe metabolic features associated with human melanoma tumors.

Detailed Description

This is a single center, correlative study designed to assess metabolic features of melanoma tumors in patients. The study will involve the collection of melanoma tissue at the time of surgical biopsy or excision. All samples will be assessed by mass spectrometry for metabolomic analysis. A subset of patients will have received \[U-13C\]glucose infusions which will be utilized for isotope tracing metabolic analysis. Relevant clinical data (eg survival, metastasis) will be correlated with metabolic findings.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Patients with known or probable malignant melanoma lesions requiring surgical biopsy or excision. * Subjects of all races and ethnic origins over age 18. Exclusion Criteria: * Not a surgical candidate * Poorly controlled diabetes

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Melanoma (Skin)

Locations

University of Texas Southwestern Medical Center

Dallas, Texas 75390

United States